Harvett,
Once again you have (deliberately?) distorted the truth.
You state that "Even a placebo with carboplatin added at AUC2 proceduced (sic) a median PFS of 20 weeks. And we are suppose to applaud for 12 weeks." What you failed to say was that carboplatin at AUC=2 in this case was administered WEEKLY.
This was equivalent to AUC=8 monthly, twice the dose used with NOX66. I'm sure you will respond with some irrelevant data that suits your purpose, but I do not care.
The great pity is that your vendetta has no doubt turned some investors off Noxopharm and thus deprived them of a windfall gain. Well done.
Add to My Watchlist
What is My Watchlist?
